Eli Lilly & Co. sent a wave of letters to US well being treatment suppliers in new times demanding they prevent endorsing copycat weight-loss medicines as supply of the business’s manufacturer-identify medicines increases. Lilly’s chief executive officer stated at the start from the month which the Zepbound shortage must https://patrickr256kct2.wikinewspaper.com/user